Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile.
Baños-Hernández CJ, Navarro-Zarza JE, Bucala R, Hernández-Bello J, Parra-Rojas I, Ramírez-Dueñas MG, García-Arellano S, Hernández-Palma LA, Machado-Sulbarán AC, Muñoz-Valle JF. Baños-Hernández CJ, et al. Among authors: ramirez duenas mg. Clin Rheumatol. 2019 Jun;38(6):1643-1654. doi: 10.1007/s10067-019-04459-8. Epub 2019 Feb 12. Clin Rheumatol. 2019. PMID: 30747392
The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-β1 serum levels but not with G915C (Arg25Pro) TGF-β1 polymorphism.
Muñoz-Valle JF, Torres-Carrillo NM, Guzmán-Guzmán IP, Torres-Carrillo N, Ruiz-Quezada SL, Palafox-Sánchez CA, Rangel-Villalobos H, Ramírez-Dueñas MG, Parra-Rojas I, Fafutis-Morris M, Bastidas-Ramírez BE, Pereira-Suárez AL. Muñoz-Valle JF, et al. Rheumatol Int. 2012 Feb;32(2):367-72. doi: 10.1007/s00296-010-1624-x. Epub 2010 Nov 27. Rheumatol Int. 2012. PMID: 21113716
Association of CD28 IVS3 +17T/C polymorphism with soluble CD28 in rheumatoid arthritis.
Ledezma-Lozano IY, Padilla-Martínez JJ, Leyva-Torres SD, Parra-Rojas I, Ramírez-Dueñas MG, Pereira-Suárez AL, Rangel-Villalobos H, Ruiz-Quezada SL, Sánchez-Hernández PE, Muñoz-Valle JF. Ledezma-Lozano IY, et al. Dis Markers. 2011;30(1):25-9. doi: 10.3233/DMA-2011-0760. Dis Markers. 2011. PMID: 21508506 Free PMC article.
MIF and TNFα serum levels in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: a cross-sectional study.
Brennan-Bourdon LM, De la Cruz-Mosso U, Reyes-Castillo Z, Martínez-Bonilla GE, Ramírez-Dueñas MG, Islas-Carbajal MC, Rincón-Sánchez AR, Salazar-Páramo M, Muñoz-Valle JF. Brennan-Bourdon LM, et al. Immunopharmacol Immunotoxicol. 2015 Apr;37(2):207-13. doi: 10.3109/08923973.2015.1017645. Epub 2015 Feb 27. Immunopharmacol Immunotoxicol. 2015. PMID: 25721154
Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla GE, del Toro-Arreola S, Ramírez-Dueñas MG, Ocampo-Bermudes G, Muñoz-Valle JF. Reyes-Castillo Z, et al. Clin Exp Immunol. 2015 Nov;182(2):119-31. doi: 10.1111/cei.12677. Epub 2015 Sep 16. Clin Exp Immunol. 2015. PMID: 26149185 Free PMC article.
KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.
Velarde-de la Cruz EE, Sánchez-Hernández PE, Muñoz-Valle JF, Palafox-Sánchez CA, Ramírez-de Los Santos S, Graciano-Machuca O, García-Iglesias T, Montoya-Buelna M, Ramírez-Dueñas MG. Velarde-de la Cruz EE, et al. Immunopharmacol Immunotoxicol. 2016 Aug;38(4):303-9. doi: 10.1080/08923973.2016.1194429. Immunopharmacol Immunotoxicol. 2016. PMID: 27251940 Clinical Trial.
30 results